Neuropharmacology & CNS Therapeutics

Neuropharmacology continues to evolve with breakthroughs in brain-targeted therapies. This track will spotlight treatments for neurological disorders such as Alzheimer’s, Parkinson’s, epilepsy, and depression. Cutting-edge research in blood–brain barrier penetration and neuromodulation will be covered. Experts will also discuss psychiatric drug development challenges. Emerging tools such as optogenetics and neuroimaging will be highlighted. Delegates will explore future directions in CNS drug innovation.

    Related Conference of Neuropharmacology & CNS Therapeutics

    July 27-28, 2026

    19th World Drug Delivery Summit

    Paris, France
    July 27-28, 2026

    39th World Congress on Pharmacology

    Rome, Italy
    September 24-25, 2026

    6th World Congress on Rare Diseases & Orphan Drugs

    Paris, France
    November 26-27, 2026

    5th World Congress on Precision and Personalized Medicine

    Zurich, Switzerland
    November 26-27, 2026

    5th World Conference on Pharma Industry and Medical Devices

    Zurich, Switzerland

    Neuropharmacology & CNS Therapeutics Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in